Clinical Trial Detail

NCT ID NCT02576444
Title OLAParib COmbinations (OLAPCO)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors Yale University
Indications

Advanced Solid Tumor

Therapies

Adavosertib + Olaparib

Olaparib

Olaparib + Vistusertib

Capivasertib + Olaparib

AZD6738 + Olaparib

Age Groups: adult senior

Additional content available in CKB BOOST